Your browser doesn't support javascript.
loading
Validation of the cell cycle progression score to differentiate indolent from aggressive prostate cancer in men diagnosed through transurethral resection of the prostate biopsy.
Cuzick, Jack M; Stone, Steven; Lenz, Lauren; Flake, Darl D; Rajamani, Saradha; Moller, Henrik; Berney, Daniel Maurice; Cohen, Todd; Scardino, Peter T.
Afiliación
  • Cuzick JM; Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK.
  • Stone S; Myriad Genetics, Inc., Salt Lake City, Utah, USA.
  • Lenz L; Myriad Genetics, Inc., Salt Lake City, Utah, USA.
  • Flake DD; Myriad Genetics, Inc., Salt Lake City, Utah, USA.
  • Rajamani S; Myriad Genetics, Inc., Salt Lake City, Utah, USA.
  • Moller H; Department of Cancer Epidemiology, Population and Global Health, King's College London, London, UK.
  • Berney DM; Department of Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.
  • Cohen T; Myriad Genetics, Inc., Salt Lake City, Utah, USA.
  • Scardino PT; Department of Urology, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
Cancer Rep (Hoboken) ; 5(8): e1535, 2022 08.
Article en En | MEDLINE | ID: mdl-34423592
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Neoplasias de la Próstata / Resección Transuretral de la Próstata Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans / Male Idioma: En Revista: Cancer Rep (Hoboken) Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Neoplasias de la Próstata / Resección Transuretral de la Próstata Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans / Male Idioma: En Revista: Cancer Rep (Hoboken) Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido